Shares of CRH Medical Corp (TSE:CRH) have received a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is C$6.75.
Several equities analysts have recently issued reports on the company. TD Securities restated a “buy” rating and set a C$12.00 target price on shares of CRH Medical Corp in a research report on Friday, April 28th. Royal Bank Of Canada decreased their target price on CRH Medical Corp from C$11.00 to C$10.00 and set a “sector perform” rating for the company in a research report on Friday, April 28th. Scotiabank decreased their target price on CRH Medical Corp from C$10.25 to C$9.75 and set an “outperform” rating for the company in a research report on Tuesday, April 25th. Bloom Burton lowered CRH Medical Corp from a “buy” rating to an “accumulate” rating in a research report on Friday, July 14th. Finally, National Bank Financial decreased their price objective on CRH Medical Corp from C$9.00 to C$7.00 in a research report on Monday, July 17th.
Shares of CRH Medical Corp (TSE:CRH) traded down 6.69% during midday trading on Friday, reaching $2.93. 1,031,021 shares of the company traded hands. The company has a 50 day moving average of $5.84 and a 200 day moving average of $8.36. CRH Medical Corp has a 12 month low of $2.90 and a 12 month high of $12.35. The firm has a market capitalization of $216.58 million and a P/E ratio of 24.02.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://baseballnewssource.com/markets/crh-medical-corp-tsecrh-receives-average-recommendation-of-buy-from-analysts-updated-updated-updated/1196269.html.
In other CRH Medical Corp news, Director David Johnson sold 30,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of C$5.67, for a total value of C$170,100.00.
CRH Medical Corp Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with our FREE daily email newsletter.